Italia markets closed

BMY Sep 2024 62.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0800-0,1800 (-69,23%)
Alla chiusura: 03:07PM EDT
Schermo intero
Chiusura precedente0,2600
Aperto0,1000
Denaro0,0700
Lettera0,0800
Prezzo d'esercizio62,50
Scadenza2024-09-20
Min-Max giorno0,0800 - 0,1000
Contratto - Min-MaxN/D
Volume202
Open Interest68
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri